Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations?
Authors : De Silva P, Aiello M, Gu-Trantien C, Migliori E, Willard-Gallo K, Solinas C Year : 2021 Journal : Int J Cancer
Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression.
Authors : Pellegrino B, Hlavata Z, Migali C, De Silva P, Aiello M, Willard-Gallo K, Musolino A, Solinas C Year : 2021 Journal : Mol Diagn Ther
A review of immune checkpoint blockade in breast cancer.
Authors : Pellegrino B, Tommasi C, Cursio OE, Musolino A, Migliori E, De Silva P, Senevirathne TH, Schena M, Scartozzi M, Farci D, Willard-Gallo K, Solinas C Year : 2021 Journal : Semin Oncol
Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity.
Authors : Noël G, Fontsa ML, Garaud S, De Silva P, de Wind A, Van den Eynden GG, Salgado R, Boisson A, Locy H, Thomas N, Solinas C, Migliori E, Naveaux C, Duvillier H, Lucas S, Craciun L, Thielemans K, Larsimont D, Willard-Gallo K Year : 2021 Journal : J Clin Invest
Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review.
Authors : Pellegrino B, Musolino A, Llop-Guevara A, Serra V, De Silva P, Hlavata Z, Sangiolo D, Willard-Gallo K, Solinas C Year : 2020 Journal : Transl Oncol